Every year the FTC brings hundreds of cases against individuals and companies for violating consumer protection and competition laws that the agency enforces. These cases can involve fraud, scams, identity theft, false advertising, privacy violations, anti-competitive behavior and more. The Legal Library has detailed information about cases we have brought in federal court or through our internal administrative process, called an adjudicative proceeding.
Displaying 61 - 72 of 72
Actavis Group hf. and Abrika Pharmaceuticals, Inc., In the Matter of
The Commission prevented a merger-to-monopoly in the sale of generic isradipine capsules by challenging the proposed $235 million purchase of Abrika Pharmaceuticals, Inc., by the Actavis Group, an international generic pharmaceuticals company. To maintain competition in the market for this important generic drug, used to lower blood pressure and to treat hypertension, ischemia, and depression, the consent order requires the divestiture of all rights and assets necessary to produce, market, and sell generic isradipine to Cobalt Laboratories, Inc.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0710063
MiRealSource, Inc., In the Matter of
The Commission filed an administrative complaint challenging a set of rules adopted by MiRealSource, Inc. to keep Exclusive Agency Listings from being listed on its MLS, as well as other rules that restricted competition in real estate brokerage services. The complaint alleges that the conduct was collusive and exclusionary, because in agreeing to keep non-traditional listings off the MLS or from public Web sites, the brokers enacting the rules were, in effect, agreeing among themselves to limit the manner in which they compete with one another, and withholding valuable benefits of the MLS from real estate brokers who did not go along. On February 5, 2007 the Commission approved a consent order in which MiRealSource agreed to abandon such collusive conduct and provide its services to all member brokers representing potential home sellers, regardless of the type of listing contract that they choose.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0610266
Docket Number
9321
Hologic Inc., In the Matter of
The Commission approved a final consent order to ensure the maintenance of competition in the market for prone stereotactic breast biopsy systems (SBBSs). The Commission had challenged this merger which was consummated in 2005. The order required the divestiture of all prone SBBS assets to Siemens, a company well-positioned to become a competitor in this market.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0510263
Ballenger Group, LLC, and Ballenger Holdings, LL
Type of Action
Federal
Last Updated
FTC Matter/File Number
0223171
QBI, Inc., and Jeffrey Allen Donohue
Type of Action
Federal
Last Updated
FTC Matter/File Number
992-3196
Statement
Date
By
Orson Swindle, Former Commissioner
Good Morning, Mr. Chairman and members of the Subcommittee Thank you for addressing this most important issue. My brief remarks focus on two concerns: first, any consumer privacy policy must not...
Statement of Commissioner Mary L. Azcuenaga in The Boeing Company
Date
By
Mary L. Azcuenaga, Former Commissioner
Matter Number
971 0051
The Commission today announces that it will not challenge the proposed merger of The Boeing Company and McDonnell Douglas Corporation. I agree that no action is warranted against the combination of...
Displaying 61 - 72 of 72